Sanofi and Regeneron to Present Results from Phase 3 Praluent® (alirocumab) Injection Clinical Trials at AHA Scientific Sessions 2015
Go back to Sanofi and Regeneron to Present Results from Phase 3 Praluent® (alirocumab) Injection Clinical Trials at AHA Scientific Sessions 2015| Regeneron (NASDAQ: REGN) | Delayed: 608.06 -1.88 (0.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $609.94 | 52 Week High | $592.36 | |||
| Open | $604.46 | 52 Week Low | $325.35 | |||
| Day High | $612.70 | P/E | 159.60 | |||
| Day Low | $594.90 | EPS | $3.81 | |||
| Volume | 483,703 | |||||
| BANCO SANTANDER S.A. (NYSE: SAN) | Delayed: 13.70 +0.20 (1.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.50 | 52 Week High | $5.58 | |||
| Open | $13.70 | 52 Week Low | $3.60 | |||
| Day High | $13.75 | P/E | N/A | |||
| Day Low | $13.65 | EPS | $0.00 | |||
| Volume | 3,453,709 | |||||
| SANOFI (NASDAQ: SNY) | Delayed: 41.60 -0.78 (1.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $42.38 | 52 Week High | $44.76 | |||
| Open | $40.91 | 52 Week Low | $36.81 | |||
| Day High | $41.67 | P/E | N/A | |||
| Day Low | $40.89 | EPS | $0.00 | |||
| Volume | 3,554,490 | |||||
